Expert consensus: main risk factors for poor prognosis in COVID-19 and the implications for targeted measures against SARS-CoV-2

FJ Candel, P Barreiro, M Salavert, A Cabello… - Viruses, 2023 - mdpi.com
The clinical evolution of patients infected with the Severe Acute Respiratory Coronavirus
type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The …

Coronavirus disease 2019 in immunocompromised patients: a comprehensive review of coronavirus disease 2019 in hematopoietic stem cell recipients

A Lafarge, A Mabrouki, E Yvin, S Bredin… - Current Opinion in …, 2022 - journals.lww.com
Further studies are warranted to determine the proper impact of HSCT-related immune
disorders on COVID-19 outcomes, and to evaluate specific treatments and vaccination …

[PDF][PDF] COVID-19 in the immunocompromised host, including people with human immunodeficiency virus

N Jakharia, AK Subramanian, AE Shapiro - Infectious Disease Clinics of …, 2022 - Elsevier
This review describes the incidence, epidemiology, and risk factors for mortality of COVID-19
in immunocompromised patients, including persons with HIV. We describe various …

COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation

Q Wen, Z Guo, XH Zhang, LP Xu, Y Wang, CH Yan… - Scientific Reports, 2024 - nature.com
We aimed to identify the severity and duration of COVID-19 infection on complications after
allo-HSCT. Enrolled 179 hospitalized patients with COVID-19 were categorized into long …

Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient− clinical spectrum and outcome

M Fernández-Ruiz, JM Aguado - Current Opinion in Infectious …, 2021 - journals.lww.com
Severe acute respiratory syndrome coronavirus 2 infection in... : Current Opinion in Infectious
Diseases Severe acute respiratory syndrome coronavirus 2 infection in the stem cell …

COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis

YJ Lim, U Khan, I Karpha, A Ross, M Saif… - …, 2022 - Wiley Online Library
Up‐to‐date information on coronavirus disease 2019 (COVID‐19) outcomes and risk factors
in haematopoietic cell transplantation (HCT) recipients is required to inform on decisions …

Impact of Respiratory Syncytial Virus (RSV) on adult haematology oncology patients

F Farina, D Sannipoli, E Diral, S Mastaglio… - Journal of …, 2024 - journalofinfection.com
Dear Editor, respiratory syncytial virus (RSV) is primarily associated with severe respiratory
infections in children and newborns; however, it also poses a significant risk in elderly and …

Zelltherapie in den Zeiten von SARS-CoV-2

E Wiercinska, H Bönig - Transfusionsmedizin, 2022 - thieme-connect.com
Ein breites Spektrum von Disruptionen, aber auch blitzschnelle Innovationen, hat die SARS-
CoV-2 Pandemie gebracht. Dieser Übersichtsartikel betrachtet die Pandemie aus der Warte …